Follow
Sanjay Asthana
Sanjay Asthana
Professor of Medicine, University of Wisconsin-Madison
Verified email at medicine.wisc.edu
Title
Cited by
Cited by
Year
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ...
Nature genetics 51 (3), 414-430, 2019
24152019
Gut microbiome alterations in Alzheimer’s disease
NM Vogt, RL Kerby, KA Dill-McFarland, SJ Harding, AP Merluzzi, ...
Scientific reports 7 (1), 13537, 2017
17792017
Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis
Y Iturria-Medina, RC Sotero, PJ Toussaint, JM Mateos-Pérez, AC Evans
Nature communications 7 (1), 11934, 2016
10542016
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ...
Nature genetics 49 (9), 1373-1384, 2017
9512017
Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study
GS Watson, BA Cholerton, MA Reger, LD Baker, SR Plymate, S Asthana, ...
The American journal of geriatric psychiatry 13 (11), 950-958, 2005
7842005
Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial
MW Dysken, M Sano, S Asthana, JE Vertrees, M Pallaki, M Llorente, ...
Jama 311 (1), 33-44, 2014
7592014
Testosterone supplementation improves spatial and verbal memory in healthy older men
MM Cherrier, S Asthana, S Plymate, L Baker, AM Matsumoto, E Peskind, ...
Neurology 57 (1), 80-88, 2001
5952001
Plasma tau in Alzheimer disease
N Mattsson, H Zetterberg, S Janelidze, PS Insel, U Andreasson, ...
Neurology 87 (17), 1827-1835, 2016
5062016
Effects of hormone therapy on cognition and mood in recently postmenopausal women: findings from the randomized, controlled KEEPS–cognitive and affective study
CE Gleason, NM Dowling, W Wharton, JAE Manson, VM Miller, ...
PLoS medicine 12 (6), e1001833, 2015
4932015
Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose
S Craft, S Asthana, JW Newcomer, CW Wilkinson, IT Matos, LD Baker, ...
Archives of general psychiatry 56 (12), 1135-1140, 1999
4391999
Association of insulin resistance with cerebral glucose uptake in late middle–aged adults at risk for Alzheimer disease
AA Willette, BB Bendlin, EJ Starks, AC Birdsill, SC Johnson, BT Christian, ...
JAMA neurology 72 (9), 1013-1020, 2015
4192015
In vivo staging of regional amyloid deposition
MJ Grothe, H Barthel, J Sepulcre, M Dyrba, O Sabri, SJ Teipel, ...
Neurology 89 (20), 2031-2038, 2017
4092017
Insulin increases CSF Aβ42 levels in normal older adults
GS Watson, ER Peskind, S Asthana, K Purganan, C Wait, D Chapman, ...
Neurology 60 (12), 1899-1903, 2003
3932003
High-dose estradiol improves cognition for women with AD: results of a randomized study
S Asthana, LD Baker, S Craft, FZ Stanczyk, RC Veith, MA Raskind, ...
Neurology 57 (4), 605-612, 2001
3722001
The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease
NM Vogt, KA Romano, BF Darst, CD Engelman, SC Johnson, ...
Alzheimer's research & therapy 10, 1-8, 2018
3542018
Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
S Palmqvist, H Zetterberg, N Mattsson, P Johansson, ...
Neurology 85 (14), 1240-1249, 2015
3492015
Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment
MM Cherrier, AM Matsumoto, JK Amory, S Asthana, W Bremner, ...
Neurology 64 (12), 2063-2068, 2005
3472005
Insulin dose–response effects on memory and plasma amyloid precursor protein in Alzheimer’s disease: interactions with apolipoprotein E genotype
S Craft, S Asthana, DG Cook, LD Baker, M Cherrier, K Purganan, C Wait, ...
Psychoneuroendocrinology 28 (6), 809-822, 2003
3452003
Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer’s disease: results of a placebo-controlled, double-blind, pilot study
S Asthana, S Craft, LD Baker, MA Raskind, RS Birnbaum, CP Lofgreen, ...
Psychoneuroendocrinology 24 (6), 657-678, 1999
3171999
Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE
S Ayton, NG Faux, AI Bush
Nature communications 6 (1), 6760, 2015
3132015
The system can't perform the operation now. Try again later.
Articles 1–20